Statera Biopharma (STAB) Stock Price
Statera Biopharma Price
Over the last 17 years Statera Biopharma grew revenue by 5.1% annually, reaching 1.49 M USD. For Statera Biopharma, the net margin of -6,835.6% is down versus -497.9% a few years ago.
Statera Biopharma stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Statera Biopharma business model & stock analysis
Frequently asked questions about Statera Biopharma
Converted at the current exchange rate, the Statera Biopharma share trades at 0.00 EUR (0.00 USD).
The Statera Biopharma share (STAB) is listed on 2 stock exchanges, including: NASDAQ (STAB), Frankfurt (7CB0.F).
The revenue cannot currently be calculated for Statera Biopharma.
The profit cannot currently be calculated for Statera Biopharma.
The P/E ratio cannot be calculated for Statera Biopharma at the moment.
The P/S cannot be calculated for Statera Biopharma currently.
The Eulerpool Quality Score for Statera Biopharma is 3/10.
The ISIN of Statera Biopharma is US8575611046. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Statera Biopharma is STAB. The ticker symbol is used to trade Statera Biopharma shares on the stock exchange.
Statera Biopharma stock
Statera Biopharma Peer Group
Statera Biopharma Ticker
Statera Biopharma FIGI
All fundamentals and in-depth analysis of Statera Biopharma
Our stock analysis for Statera Biopharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Statera Biopharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.